Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.03B |
| 2 |
McDonald's
MCD
|
+$609M |
| 3 |
UnitedHealth
UNH
|
+$598M |
| 4 |
Strategy Inc
MSTR
|
+$514M |
| 5 |
Qualcomm
QCOM
|
+$469M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.14B |
| 2 |
NVIDIA
NVDA
|
+$1.53B |
| 3 |
Eli Lilly
LLY
|
+$1.08B |
| 4 |
Mastercard
MA
|
+$996M |
| 5 |
Uber
UBER
|
+$932M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.27% |
| 2 | Consumer Discretionary | 12.49% |
| 3 | Financials | 11.57% |
| 4 | Healthcare | 9.6% |
| 5 | Communication Services | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
iShares MSCI Hong Kong ETF
EWH
$1.22B
| $471K | ﹤0.01% |
23,414
+1,714
| +8% | +$31.3K |
|
1327
Bio-Rad Laboratories Class A
BIO
$8.42B
| $470K | ﹤0.01% |
1,876
-21,460
| -92% | -$5.07M |
|
1328
Bankunited
BKU
$3.38B
| $465K | ﹤0.01% |
12,377
-17,741
| -59% | -$596K |
|
1329
Independent Bank
INDB
$4.05B
| $464K | ﹤0.01% |
7,009
-10,071
| -59% | -$612K |
|
1330
Unifirst Corp
UNF
$5.32B
| $462K | ﹤0.01% |
+2,700
| New | +$490K |
|
|
BDN
1331
Brandywine Realty Trust
BDN
$551M
| $461K | ﹤0.01% |
111,982
-64,390
| -37% | -$267K |
|
1332
PENN Entertainment
PENN
$2.74B
| $461K | ﹤0.01% |
24,754
+24,708
| +53,713% | +$388K |
|
1333
Enovix
ENVX
$862M
| $457K | ﹤0.01% |
46,990
-213,521
| -82% | -$1.39M |
|
|
CCC
1334
CCC Intelligent Solutions
CCC
$3.42B
| $456K | ﹤0.01% |
47,468
+28,809
| +154% | +$258K |
|
1335
Yext
YEXT
$501M
| $456K | ﹤0.01% |
55,488
-3,030
| -5% | -$21.2K |
|
|
PDM
1336
Piedmont Realty Trust
PDM
$1.22B
| $454K | ﹤0.01% |
60,906
-653,641
| -91% | -$4.52M |
|
1337
PDF Solutions
PDFS
$2.13B
| $452K | ﹤0.01% |
20,017
+75
| +0.4% | +$1.42K |
|
1338
Bank of Hawaii
BOH
$3.33B
| $451K | ﹤0.01% |
6,365
-10,213
| -62% | -$679K |
|
1339
Provident Financial Services
PFS
$3.11B
| $451K | ﹤0.01% |
24,595
-33,110
| -57% | -$549K |
|
1340
Q2 Holdings
QTWO
$3.42B
| $448K | ﹤0.01% |
4,853
-26,285
| -84% | -$2.22M |
|
1341
MasTec
MTZ
$26.7B
| $446K | ﹤0.01% |
2,634
+2,624
| +26,240% | +$378K |
|
1342
Medifast
MED
$108M
| $445K | ﹤0.01% |
30,439
| – | – |
|
1343
Cushman & Wakefield Ltd
CWK
$2.98B
| $444K | ﹤0.01% |
38,108
-54,150
| -59% | -$531K |
|
1344
Steven Madden
SHOO
$3.12B
| $442K | ﹤0.01% |
16,941
-18,519
| -52% | -$434K |
|
1345
HNI Corp
HNI
$3B
| $441K | ﹤0.01% |
8,533
-13,564
| -61% | -$614K |
|
1346
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $438K | ﹤0.01% |
15,972
| – | – |
|
1347
Acadia Pharmaceuticals
ACAD
$4.25B
| $433K | ﹤0.01% |
+20,401
| New | +$379K |
|
1348
PubMatic
PUBM
$581M
| $432K | ﹤0.01% |
+34,101
| New | +$359K |
|
1349
Arrowhead Research
ARWR
$12.1B
| $426K | ﹤0.01% |
25,194
+19,867
| +373% | +$285K |
|
|
ACH
1350
Accendra Health
ACH
$240M
| $423K | ﹤0.01% |
45,498
+18,559
| +69% | +$137K |
|
Similar funds
Amundi's Q2 2025 Portfolio in Review
As of Q2 2025, Amundi held 2,245 positions worth $290B, up 5.5% from $275B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Amundi withdrew a net $25.8B in Q2 2025, closing 579 positions and reducing 831 holdings. Its most notable exit was Novo Nordisk, an estimated $332M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Amundi opened a new position in Victory Capital Holdings worth $213M.
- Amundi's largest Q2 2025 buy was Victory Capital Holdings: 3,293,471 shares worth $213M.
- Amundi added most to Tesla in Q2 2025, an estimated $1.03B increase.
- Amundi's biggest Q2 2025 reduction was Microsoft, cutting an estimated $3.14B.
- Amundi fully exited Novo Nordisk in Q2 2025, selling an estimated $332M.
- Amundi's ten largest holdings make up 31% of its $290B portfolio in Q2 2025.
- Amundi opened 66 new positions and closed 579 in Q2 2025.
- Amundi's portfolio value rose 5.5% quarter-over-quarter to $290B.
Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.